We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of CLVS yet.

CLVS Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2023, worth a combined $0 — down 100% from $11K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CLVS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Coppell Advisory Solutions, exiting entirely with an estimated $11K sold.

  • 0 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2023, down from 1 in Q3 2023.
  • Funds reported $0 of Clovis Oncology, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Clovis Oncology, Inc. positions in Q4 2023 and 1 closed out, a net change of -1 holder.
  • The largest Clovis Oncology, Inc. seller in Q4 2023 was Coppell Advisory Solutions, an estimated $11K sold.

Based on aggregated 13F filings for Q4 2023.